XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2021
Sep. 30, 2020
Current assets:    
Cash and cash equivalents $ 6,554,948 $ 7,786,743
Accounts receivable, net of allowance of $29,821 and $11,968 at September 30, 2021 and 2020, respectively 2,804,039 194,319
Inventories 1,369,933 497,367
Prepaid expenses and other current assets 568,881 599,296
Total current assets 11,297,801 9,077,725
Property and equipment, net 3,023,915 1,277,655
Other assets:    
Deposits 95,040 95,083
Goodwill   285,386
Intangible assets, net   605,330
Total Assets 14,416,756 11,341,179
Current liabilities:    
Accounts payable and accrued liabilities 2,991,343 1,926,427
Promissory notes payable-current portion   329,299
Secured convertible notes payable, net of debt issuance costs   1,499,116
Deferred revenue 281,000 511,036
Total current liabilities 3,272,343 4,265,878
Long term accrued liabilities 31,467 848,307
Promissory notes payable-long term portion   517,488
Total liabilities 3,303,810 5,631,673
Commitments and contingencies (Note K)
Applied DNA Sciences, Inc. stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2021 and 2020, respectively 0 0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2021 and 2020, 7,486,120 and 5,142,779 shares issued and outstanding as of September 30, 2021 and 2020, respectively 7,488 5,144
Additional paid in capital 295,228,272 275,548,737
Accumulated deficit (284,122,092) (269,835,650)
Applied DNA Sciences, Inc. stockholders' equity: 11,113,668 5,718,231
Noncontrolling interest (722) (8,725)
Total equity 11,112,946 5,709,506
Total liabilities and equity 14,416,756 11,341,179
Series A Preferred Stock [Member]    
Applied DNA Sciences, Inc. stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2021 and 2020, respectively 0 0
Series B Preferred Stock [Member]    
Applied DNA Sciences, Inc. stockholders' equity:    
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2021 and 2020, respectively $ 0 $ 0